Purpose: Sexual and gender minority persons in low-income countries have very limited access to routine health services. This study evaluated the feasibility of using a self-sampled human papillomavirus (HPV) test to increase access to screening for cervical cancer among transgender men in El Salvador. Methods: We partnered with a local advocacy organization for recruitment. A total of 24 transgender men (men assigned female at birth) ages 19-55 were enrolled and provided consent. Questionnaires assessed sociodemographics, health and sexual histories, and knowledge about HPV and cervical cancer. Screening was performed with a self-sampled HPV test. Participants with a positive test were offered colposcopy and cryotherapy treatment, if appropriate. Those with a negative test were advised to return in 5 years for rescreening. Results: Out of 24 consenting participants, 23 (95.83%) agreed to conduct HPV self-sampling, and 22/23 (95.65%) expressed willingness to self-sample in the future. Among self-sampled individuals, 3/23 (13%) tested positive and accepted colposcopy and biopsy. Analyses of biopsied tissue revealed one case of cervical intraepithelial neoplasia grade 1. Conclusion: HPV self-sampling and subsequent procedures were accepted by the majority of participants. This screening method may be a viable alternative to cytology among transgender men in El Salvador.
Purpose: Sexual and gender minority persons in low-income countries have very limited access to routine health services. This study evaluated the feasibility of using a self-sampled human papillomavirus (HPV) test to increase access to screening for cervical cancer among transgender men in El Salvador. Methods: We partnered with a local advocacy organization for recruitment. A total of 24 transgender men (men assigned female at birth) ages 19-55 were enrolled and provided consent. Questionnaires assessed sociodemographics, health and sexual histories, and knowledge about HPV and cervical cancer. Screening was performed with a self-sampled HPV test. Participants with a positive test were offered colposcopy and cryotherapy treatment, if appropriate. Those with a negative test were advised to return in 5 years for rescreening. Results: Out of 24 consenting participants, 23 (95.83%) agreed to conduct HPV self-sampling, and 22/23 (95.65%) expressed willingness to self-sample in the future. Among self-sampled individuals, 3/23 (13%) tested positive and accepted colposcopy and biopsy. Analyses of biopsied tissue revealed one case of cervical intraepithelial neoplasia grade 1. Conclusion:HPV self-sampling and subsequent procedures were accepted by the majority of participants. This screening method may be a viable alternative to cytology among transgender men in El Salvador.
Entities:
Keywords:
El Salvador; HPV self-sampling; LMICs; cervical cancer; sexual and gender minorities; transgender men
Authors: Sari L Reisner; Tonia Poteat; JoAnne Keatley; Mauro Cabral; Tampose Mothopeng; Emilia Dunham; Claire E Holland; Ryan Max; Stefan D Baral Journal: Lancet Date: 2016-06-17 Impact factor: 79.321
Authors: Helen Kelly; Philippe Mayaud; Michel Segondy; Nitika Pant Pai; Rosanna W Peeling Journal: Sex Transm Infect Date: 2017-12 Impact factor: 3.519
Authors: Bari Laskow; Ruben Figueroa; Karla M Alfaro; Isabel C Scarinci; Elizabeth Conlisk; Mauricio Maza; Judy C Chang; Miriam Cremer Journal: Int J Gynaecol Obstet Date: 2017-06-07 Impact factor: 3.561
Authors: Anne F Rositch; Ann Gatuguta; Robert Y Choi; Brandon L Guthrie; Romel D Mackelprang; Rose Bosire; Lucy Manyara; James N Kiarie; Jennifer S Smith; Carey Farquhar Journal: PLoS One Date: 2012-07-10 Impact factor: 3.240
Authors: Mauricio Maza; Karla Alfaro; Jillian Garai; Mario Morales Velado; Julia C Gage; Philip E Castle; Juan Felix; Silvana Luciani; Nicole Campos; Jane Kim; Rachel Masch; Miriam Cremer Journal: Gynecol Oncol Rep Date: 2017-03-03
Authors: Sari L Reisner; Madeline B Deutsch; Sarah M Peitzmeier; Jaclyn M White Hughto; Timothy P Cavanaugh; Dana J Pardee; Sarah A McLean; Lori A Panther; Marcy Gelman; Matthew J Mimiaga; Jennifer E Potter Journal: PLoS One Date: 2018-03-14 Impact factor: 3.240
Authors: Alan G Nyitray; Vanessa Schick; Michael D Swartz; Anna R Giuliano; Maria E Fernandez; Ashish A Deshmukh; Timothy J Ridolfi; Christopher Ajala; Bridgett Brzezinski; Micaela Sandoval; Belinda Nedjai; Jennifer S Smith; Elizabeth Y Chiao Journal: BMJ Open Date: 2021-06-29 Impact factor: 2.692